montelukast

{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid

UCHDWCPVSPXUMX-TZIWLTJVSA-N CHEBI:50730 11 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

11 Reactome pathways

Metabolite details

Identifier: UCHDWCPVSPXUMX-TZIWLTJVSA-N
InChI Key: UCHDWCPVSPXUMX-TZIWLTJVSA-N
IUPAC name: {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
Preferred name: montelukast
INN name: montelukast
Synonym: (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
ChEBI: CHEBI:50730

Reactome pathways

R-HSA-162582 - Signal Transduction
R-HSA-1643685 - Disease
R-HSA-372790 - Signaling by GPCR
R-HSA-373076 - Class A/1 (Rhodopsin-like receptors)
R-HSA-391903 - Eicosanoid ligand-binding receptors
R-HSA-391906 - Leukotriene receptors
R-HSA-500792 - GPCR ligand binding
R-HSA-5663205 - Infectious disease
R-HSA-9679191 - Potential therapeutics for SARS
R-HSA-9679506 - SARS-CoV Infections
R-HSA-9824446 - Viral Infection Pathways

Observed in studies

Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses

Observed in differential profiles

Control_vs_Paramycin